Clinical trials: Retinoblastoma Unilateral
Intraocular Retinoblastoma
Vincristine, Carboplatin, and Etoposide or Observation Only in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Retinoblastoma
This phase III trial is studying vincristine, carboplatin, and etoposide to see how well they work compared to observation only in treating patients who have undergone surgery for newly diagnosed retinoblastoma.
- Trial name
- NCT00335738
- Testing
- liposomal vincristine sulfate, carboplatin, etoposide
- Where
- 56 sites in United States, Australia and 3 more
- Volunteers
- 331 people
- Sponsor
- Children's Oncology Group
Unilateral Retinoblastoma
Intra-arterial Melphalan in Treating Younger Patients With Unilateral Retinoblastoma
This pilot clinical trial studies whether unilateral group D retinoblastoma, or retinoblastoma affecting one eye that has spread to the inner jelly like part of the eye, can be treated with a new technique for delivering…
- Trial name
- NCT02097134
- Testing
- Melphalan
- Where
- 12 sites in United States
- Volunteers
- 14 people
- Sponsor
- Children's Oncology Group
Retinoblastoma
Proton Beam Radiation Therapy for Intraocular and Periocular Retinoblastoma
The purpose of this trial is to evaluate proton beam radiation therapy as an alternative to external photon beam irradiation in children with retinoblastoma as a means of local tumor control and ocular retention.
- Trial name
- NCT00432445
- Testing
- Proton Beam Radiation Therapy, Ophthalmic EUA
- Where
- United States
- Volunteers
- 2 people
- Sponsor
- M.D. Anderson Cancer Center